Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2884 participants.
Also called NCT01293097
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,884 participants
- Registry
-
NCT01293097
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01293097. Randomized; no masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2011-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
- Acronym
- ISCAP
- Condition
- Non-ST Segment Elevation Myocardial Infarction
- Condition
- Unstable Angina Pectoris
- Condition
- Stable Angina Pectoris
- Intervention (Drug)
- Atorvastatin
- Intervention (Drug)
- Statin
- Lead sponsor
- Peking University First Hospital
Record details
- Record id
cardio:ct-nct01293097- Content hash
c04c178e3a2800396f1bcc4da424cc78ccc0a0873c7355faa6c864b291c1c21d